COMBINATION THERAPY WITH ANTI-VSIG4 AND ANTIPD-L1 SUPPRESS GROWTH OF TUMOR VIA CONDITIONING OF TUMOR MICROENVIRONMENT

被引：1
|
作者：
Kwon, Byoung S. [1 ]
Kim, Hye Jeong [1 ]
Lee, Joong Won [1 ]
机构：
[1] Eutilex Co Ltd, Seoul, South Korea
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.0466
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
466
引用
收藏
页码：A486 / A486
页数：1
相关论文
共 50 条
  • [1] Astragaloside IV augments anti-PD-1 therapy to suppress tumor growth in lung cancer by remodeling the tumor microenvironment
    Wu, Tao
    Wu, Shikui
    Gao, Hui
    Liu, Haolei
    Feng, Jun
    Yi, Ge
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2024, 68 (04):
  • [2] AntiPD-L1 antibody conjugated Au-SPIOs nanoplatform for enhancing radiosensitivity and triggering anti-tumor immune response
    Chengrun Du
    Jianyun Jiang
    Caifeng Wan
    Guangsen Pan
    Fangfang Kong
    Ruiping Zhai
    Chaosu Hu
    Hongmei Ying
    Scientific Reports, 12
  • [3] AntiPD-L1 antibody conjugated Au-SPIOs nanoplatform for enhancing radiosensitivity and triggering anti-tumor immune response
    Du, Chengrun
    Jiang, Jianyun
    Wan, Caifeng
    Pan, Guangsen
    Kong, Fangfang
    Zhai, Ruiping
    Hu, Chaosu
    Ying, Hongmei
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [4] Impact of tumor microenvironment on tumor growth, metastasis and response to combination therapy via microenvironment-responsive dual drug-loaded nanoparticles and radiation
    Sethi, Pallavi
    Jyoti, Amar
    Swindell, Elden
    Langner, Ulrich W.
    St Clair, William H.
    McGarry, Ronald C.
    O'Halloran, Thomas V.
    Upreti, Meenakshi
    CANCER RESEARCH, 2014, 74 (19)
  • [5] IMM20059, A NOVEL ANTI-EPN1 ANTIBODY, IN COMBINATION WITH ATEZOLIZUMAB SIGNIFICANTLY ENHANCES TUMOR REGRESSION IN THE B16.F10 SYNGENEIC MELANOMA MODEL COMPARED TO ANTIPD-L1 MONOTHERAPY
    Dowling, John
    Nikitin, Pavel
    Swider, Cezary
    Nicolescu, Chris
    Shukla, Halley
    Bingaman-Steele, Jamie
    Patel, Nirja
    Sikorski, Eden
    Harman, Benjamin
    DiMuzio, Jillian
    Lundgren, Karen
    Ohtani, Yumi
    Morin, Michael
    Robinson, Matthew
    Shen, Fang
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A859 - A859
  • [6] Radiation Therapy in Combination with Hyperthermia and Immunotherapy Inhibit Pancreatic Tumor Growth and Modulate Tumor Microenvironment in Mice
    Mahmood, J.
    Alexander, A.
    Samanta, S.
    Soman, S.
    Shukla, H.
    Davila, E.
    Carrier, F.
    Jackson, I.
    Vujaskovic, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E163 - E164
  • [7] Overcoming Tumor Resistance to Oncolyticvaccinia Virus with Anti-PD-1-Based Combination Therapy by Inducing Antitumor Immunity in the Tumor Microenvironment
    Yoo, So Young
    Badrinath, Narayanasamy
    Jeong, Su-Nam
    Woo, Hyun Young
    Heo, Jeong
    VACCINES, 2020, 8 (02) : 1 - 17
  • [8] Lipoxin A4 and its analog suppress hepatocellular carcinoma via remodeling tumor microenvironment
    Hao, Hua
    Liu, Miao
    Wu, Ping
    Cai, Lei
    Tang, Ke
    Yi, Pan
    Li, Yongsheng
    Chen, Ying
    Ye, Duyun
    CANCER LETTERS, 2011, 309 (01) : 85 - 94
  • [9] Parameters of Tumor Microenvironment Determine Effectiveness of Anti-PD-1/PD-L1 Therapy
    Tashireva, Liubov A.
    Muravyova, Dariya T.
    Popova, Natalya O.
    Goldberg, Victor E.
    Vtorushin, Sergey V.
    Perelmuter, Vladimir M.
    BIOCHEMISTRY-MOSCOW, 2021, 86 (11) : 1461 - 1468
  • [10] Parameters of Tumor Microenvironment Determine Effectiveness of Anti-PD-1/PD-L1 Therapy
    Liubov A. Tashireva
    Dariya T. Muravyova
    Natalya O. Popova
    Victor E. Goldberg
    Sergey V. Vtorushin
    Vladimir M. Perelmuter
    Biochemistry (Moscow), 2021, 86 : 1461 - 1468
12345